Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 6 | 2013 | 175 | 0.820 |
Why?
|
| Infant, Extremely Premature | 2 | 2013 | 10 | 0.530 |
Why?
|
| Enterotoxins | 2 | 2003 | 5 | 0.440 |
Why?
|
| Endotoxins | 2 | 2003 | 28 | 0.420 |
Why?
|
| Directive Counseling | 1 | 2012 | 12 | 0.420 |
Why?
|
| Professional-Family Relations | 1 | 2012 | 26 | 0.410 |
Why?
|
| Social Perception | 1 | 2012 | 23 | 0.410 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 2 | 2010 | 3 | 0.400 |
Why?
|
| Parents | 4 | 2017 | 106 | 0.390 |
Why?
|
| Sepsis | 2 | 2003 | 147 | 0.380 |
Why?
|
| Communication | 1 | 2012 | 112 | 0.380 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 161 | 0.380 |
Why?
|
| Intestinal Mucosa | 2 | 2013 | 224 | 0.360 |
Why?
|
| Rats | 8 | 2013 | 873 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2010 | 463 | 0.340 |
Why?
|
| Itraconazole | 1 | 2008 | 4 | 0.310 |
Why?
|
| Antifungal Agents | 1 | 2008 | 36 | 0.300 |
Why?
|
| Decision Making | 3 | 2017 | 227 | 0.300 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2005 | 163 | 0.280 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2010 | 5 | 0.270 |
Why?
|
| Lipopolysaccharides | 2 | 2003 | 129 | 0.260 |
Why?
|
| Anthropometry | 1 | 2005 | 38 | 0.260 |
Why?
|
| Interferon-gamma | 2 | 2003 | 111 | 0.250 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2004 | 1 | 0.240 |
Why?
|
| Catheterization | 1 | 2004 | 51 | 0.240 |
Why?
|
| Anesthetics | 1 | 2004 | 25 | 0.240 |
Why?
|
| Infant, Newborn | 7 | 2013 | 618 | 0.230 |
Why?
|
| Superantigens | 1 | 2003 | 3 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2003 | 13 | 0.220 |
Why?
|
| Acidosis, Lactic | 1 | 2002 | 1 | 0.220 |
Why?
|
| Lactates | 1 | 2002 | 6 | 0.210 |
Why?
|
| Animals | 8 | 2013 | 4634 | 0.210 |
Why?
|
| Hydrochloric Acid | 1 | 2002 | 1 | 0.210 |
Why?
|
| Citric Acid | 1 | 2002 | 3 | 0.210 |
Why?
|
| Peptic Ulcer | 1 | 2002 | 6 | 0.210 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 85 | 0.210 |
Why?
|
| Gastric Acid | 1 | 2002 | 9 | 0.210 |
Why?
|
| Liver Diseases | 1 | 2003 | 40 | 0.210 |
Why?
|
| Spleen | 1 | 2002 | 54 | 0.200 |
Why?
|
| Life Support Care | 3 | 2017 | 11 | 0.200 |
Why?
|
| Male | 12 | 2017 | 15851 | 0.180 |
Why?
|
| Stress, Psychological | 1 | 2002 | 249 | 0.170 |
Why?
|
| Documentation | 1 | 2018 | 31 | 0.160 |
Why?
|
| Fetal Viability | 1 | 2017 | 1 | 0.150 |
Why?
|
| Qualitative Research | 3 | 2017 | 113 | 0.150 |
Why?
|
| Electronic Health Records | 1 | 2018 | 66 | 0.150 |
Why?
|
| Truth Disclosure | 3 | 2012 | 9 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 156 | 0.140 |
Why?
|
| Pregnancy | 5 | 2017 | 388 | 0.120 |
Why?
|
| Perinatal Care | 1 | 2013 | 5 | 0.110 |
Why?
|
| Counseling | 1 | 2013 | 47 | 0.110 |
Why?
|
| Bile | 2 | 2003 | 5 | 0.110 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2013 | 1 | 0.110 |
Why?
|
| Bile Acids and Salts | 2 | 2003 | 11 | 0.110 |
Why?
|
| Thiazoles | 1 | 2013 | 35 | 0.110 |
Why?
|
| Alanine Transaminase | 2 | 2003 | 23 | 0.110 |
Why?
|
| Biological Availability | 2 | 2013 | 26 | 0.110 |
Why?
|
| Tape Recording | 1 | 2012 | 4 | 0.110 |
Why?
|
| Interview, Psychological | 1 | 2012 | 36 | 0.100 |
Why?
|
| Kidney Diseases | 2 | 2005 | 117 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2013 | 138 | 0.100 |
Why?
|
| Peer Group | 1 | 2012 | 40 | 0.100 |
Why?
|
| Palliative Care | 1 | 2013 | 149 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2011 | 5 | 0.100 |
Why?
|
| Cranial Sinuses | 1 | 2011 | 5 | 0.100 |
Why?
|
| Fetal Diseases | 1 | 2011 | 7 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2011 | 15 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2003 | 223 | 0.100 |
Why?
|
| Hospitals | 1 | 2012 | 157 | 0.100 |
Why?
|
| Attitude to Death | 1 | 2011 | 14 | 0.090 |
Why?
|
| Premature Birth | 1 | 2011 | 9 | 0.090 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2011 | 20 | 0.090 |
Why?
|
| Humans | 11 | 2018 | 29814 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 194 | 0.090 |
Why?
|
| Erythromycin | 1 | 2010 | 10 | 0.090 |
Why?
|
| Adult | 6 | 2013 | 8741 | 0.090 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2010 | 2 | 0.080 |
Why?
|
| Female | 8 | 2017 | 16412 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1462 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 1247 | 0.070 |
Why?
|
| Intensive Care, Neonatal | 1 | 2005 | 34 | 0.060 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2005 | 3 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 51 | 0.060 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2005 | 10 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2005 | 94 | 0.060 |
Why?
|
| Isoantibodies | 1 | 2005 | 11 | 0.060 |
Why?
|
| Vasculitis | 1 | 2005 | 32 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 98 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2005 | 46 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 52 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2004 | 112 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 147 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2003 | 3 | 0.060 |
Why?
|
| Indocyanine Green | 1 | 2003 | 3 | 0.060 |
Why?
|
| Liver Function Tests | 1 | 2003 | 27 | 0.060 |
Why?
|
| Multiple Organ Failure | 1 | 2003 | 22 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 11 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 58 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 78 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2003 | 61 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2002 | 2 | 0.050 |
Why?
|
| Portal Vein | 1 | 2003 | 39 | 0.050 |
Why?
|
| Food, Formulated | 1 | 2002 | 6 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2002 | 90 | 0.050 |
Why?
|
| Failure to Thrive | 1 | 2002 | 2 | 0.050 |
Why?
|
| Hypokalemia | 1 | 2002 | 7 | 0.050 |
Why?
|
| Alkalosis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Splenectomy | 1 | 2002 | 7 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2002 | 325 | 0.050 |
Why?
|
| Hypertension | 1 | 2002 | 272 | 0.040 |
Why?
|
| Nursing Methodology Research | 2 | 2011 | 24 | 0.040 |
Why?
|
| Midwestern United States | 1 | 2018 | 67 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2002 | 1823 | 0.040 |
Why?
|
| Health Personnel | 1 | 2018 | 115 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2018 | 158 | 0.040 |
Why?
|
| Syndrome | 2 | 2005 | 88 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 2013 | 7 | 0.030 |
Why?
|
| Vascular Access Devices | 1 | 2013 | 3 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 28 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2011 | 1187 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2013 | 144 | 0.030 |
Why?
|
| Meglumine | 1 | 2011 | 2 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 14 | 0.020 |
Why?
|
| Gestational Age | 1 | 2011 | 75 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2011 | 8 | 0.020 |
Why?
|
| Neonatal Nursing | 1 | 2011 | 20 | 0.020 |
Why?
|
| Life Change Events | 1 | 2011 | 36 | 0.020 |
Why?
|
| Contrast Media | 1 | 2011 | 125 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2010 | 2 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 2 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 9 | 0.020 |
Why?
|
| Midazolam | 1 | 2010 | 12 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2010 | 68 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 67 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 228 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 231 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2010 | 218 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 178 | 0.020 |
Why?
|
| Mothers | 1 | 2011 | 178 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 347 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 400 | 0.020 |
Why?
|
| Role | 1 | 2005 | 8 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2005 | 27 | 0.020 |
Why?
|
| Informed Consent | 1 | 2005 | 19 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2005 | 19 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 54 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 2005 | 26 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2005 | 10 | 0.020 |
Why?
|
| Peroxidase | 1 | 2005 | 18 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2005 | 17 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2005 | 24 | 0.020 |
Why?
|
| Autoantigens | 1 | 2005 | 39 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 2005 | 61 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2005 | 30 | 0.020 |
Why?
|
| Emergencies | 1 | 2005 | 39 | 0.020 |
Why?
|
| Dyspnea | 1 | 2005 | 36 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2005 | 75 | 0.020 |
Why?
|
| Young Adult | 1 | 2011 | 1966 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 149 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 403 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 3325 | 0.010 |
Why?
|
| Spironolactone | 1 | 2002 | 3 | 0.010 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 2002 | 3 | 0.010 |
Why?
|
| Amiloride | 1 | 2002 | 7 | 0.010 |
Why?
|
| Electrolytes | 1 | 2002 | 14 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2002 | 23 | 0.010 |
Why?
|
| Diuretics | 1 | 2002 | 17 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2002 | 53 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2002 | 252 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 224 | 0.010 |
Why?
|